-
Something wrong with this record ?
Enterocytozoon Bieneusi Infects Children With Inflammatory Bowel Disease Undergoing Immunosuppressive Treatment
Ż. Zajączkowska, K. Akutko, M. Kváč, B. Sak, M. Szydłowicz, AB. Hendrich, B. Iwańczak, M. Kicia
Language English Country Switzerland
Document type Journal Article
NLK
Directory of Open Access Journals
from 2014
Free Medical Journals
from 2014
PubMed Central
from 2014
Europe PubMed Central
from 2014
Open Access Digital Library
from 2014-01-01
Open Access Digital Library
from 2014-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2014
- Publication type
- Journal Article MeSH
Objectives: Patients with inflammatory bowel disease (IBD) are susceptible to intestinal opportunistic infections due to both defective mucosal immunity and altered immune response resulting from immunosuppressive treatment. Microsporidia infecting the gastrointestinal tract and causing diarrhoea can potentially affect the course of IBD. Methods: Stool samples (90 IBD children and 121 healthy age-matched controls) were screened for Encephalitozoon spp. and Enterocytozoon bieneusi by microscopy and polymerase chain reaction followed by sequencing. Results:E. bieneusi genotype D was found in seven out of 90 (7.8%) IBD children. No children from the control group were infected, making the pathogen prevalence in the IBD group significant (P = 0.002). Furthermore, infection was confirmed only in patients receiving immunosuppressive treatment (P = 0.013). Conclusions: Children with IBD are at risk of intestinal E. bieneusi infection, especially when receiving immunosuppressive treatment. Therefore, microsporidia should be considered as a significant infectious agent in this group of patients.
Biology Centre of the Czech Academy of Sciences Institute of Parasitology Ceské Budějovice Czechia
Department of Biology and Medical Parasitology Wrocław Medical University Wrocław Poland
Faculty of Agriculture University of South Bohemia Ceské Budějovice Czechia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22001658
- 003
- CZ-PrNML
- 005
- 20220112153653.0
- 007
- ta
- 008
- 220107s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fmed.2021.741751 $2 doi
- 035 __
- $a (PubMed)34660646
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Zajączkowska, Żaneta $u Department of Biology and Medical Parasitology, Wrocław Medical University, Wrocław, Poland
- 245 10
- $a Enterocytozoon Bieneusi Infects Children With Inflammatory Bowel Disease Undergoing Immunosuppressive Treatment / $c Ż. Zajączkowska, K. Akutko, M. Kváč, B. Sak, M. Szydłowicz, AB. Hendrich, B. Iwańczak, M. Kicia
- 520 9_
- $a Objectives: Patients with inflammatory bowel disease (IBD) are susceptible to intestinal opportunistic infections due to both defective mucosal immunity and altered immune response resulting from immunosuppressive treatment. Microsporidia infecting the gastrointestinal tract and causing diarrhoea can potentially affect the course of IBD. Methods: Stool samples (90 IBD children and 121 healthy age-matched controls) were screened for Encephalitozoon spp. and Enterocytozoon bieneusi by microscopy and polymerase chain reaction followed by sequencing. Results:E. bieneusi genotype D was found in seven out of 90 (7.8%) IBD children. No children from the control group were infected, making the pathogen prevalence in the IBD group significant (P = 0.002). Furthermore, infection was confirmed only in patients receiving immunosuppressive treatment (P = 0.013). Conclusions: Children with IBD are at risk of intestinal E. bieneusi infection, especially when receiving immunosuppressive treatment. Therefore, microsporidia should be considered as a significant infectious agent in this group of patients.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Akutko, Katarzyna $u Department and Clinic of Paediatrics, Gastroenterology and Nutrition, Wrocław Medical University, Wrocław, Poland
- 700 1_
- $a Kváč, Martin $u Biology Centre of the Czech Academy of Sciences, Institute of Parasitology, Ceské Budějovice, Czechia $u Faculty of Agriculture, University of South Bohemia, Ceské Budějovice, Czechia
- 700 1_
- $a Sak, Bohumil $u Biology Centre of the Czech Academy of Sciences, Institute of Parasitology, Ceské Budějovice, Czechia
- 700 1_
- $a Szydłowicz, Magdalena $u Department of Biology and Medical Parasitology, Wrocław Medical University, Wrocław, Poland
- 700 1_
- $a Hendrich, Andrzej B $u Department of Biology and Medical Parasitology, Wrocław Medical University, Wrocław, Poland
- 700 1_
- $a Iwańczak, Barbara $u Department and Clinic of Paediatrics, Gastroenterology and Nutrition, Wrocław Medical University, Wrocław, Poland
- 700 1_
- $a Kicia, Marta $u Department of Biology and Medical Parasitology, Wrocław Medical University, Wrocław, Poland
- 773 0_
- $w MED00188756 $t Frontiers in medicine $x 2296-858X $g Roč. 8, č. - (2021), s. 741751
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34660646 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220107 $b ABA008
- 991 __
- $a 20220112153649 $b ABA008
- 999 __
- $a ind $b bmc $g 1745562 $s 1152805
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 8 $c - $d 741751 $e 20210930 $i 2296-858X $m Frontiers in medicine $n Front. med. $x MED00188756
- LZP __
- $a Pubmed-20220107